|
G |
Abcc3 |
ATP-binding cassette, sub-family C member 3 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of ABCC3 mRNA |
CTD |
PMID:26519955 |
|
NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ABCG5 mRNA |
CTD |
PMID:35739755 |
|
NCBI chr17:84,965,602...84,990,439
Ensembl chr17:84,965,662...84,990,439
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of ACAA2 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr18:74,912,283...74,939,278
Ensembl chr18:74,912,268...74,939,279
|
|
G |
Acaca |
acetyl-Coenzyme A carboxylase alpha |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACACA mRNA |
CTD |
PMID:35739755 |
|
NCBI chr11:84,020,461...84,292,477
Ensembl chr11:84,020,498...84,292,477
|
|
G |
Acly |
ATP citrate lyase |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA |
CTD |
PMID:35739755 |
|
NCBI chr11:100,367,178...100,418,826
Ensembl chr11:100,367,179...100,418,826
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of ACOT1 mRNA |
CTD |
PMID:26519955 |
|
NCBI chr12:84,056,276...84,064,444
Ensembl chr12:84,056,264...84,065,145
|
|
G |
Acox1 |
acyl-Coenzyme A oxidase 1, palmitoyl |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of ACOX1 mRNA |
CTD |
PMID:35739755 |
|
NCBI chr11:116,062,714...116,089,605
Ensembl chr11:116,062,714...116,089,871
|
|
G |
Acta2 |
actin alpha 2, smooth muscle, aorta |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACTA2 mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACTA2 protein |
CTD |
PMID:35739755 |
|
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased phosphorylation of AKT1 protein |
CTD |
PMID:35739755 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Akt2 |
thymoma viral proto-oncogene 2 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased phosphorylation of AKT2 protein |
CTD |
PMID:35739755 |
|
NCBI chr 7:27,290,977...27,340,251
Ensembl chr 7:27,290,977...27,340,251
|
|
G |
Akt3 |
thymoma viral proto-oncogene 3 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased phosphorylation of AKT3 protein |
CTD |
PMID:35739755 |
|
NCBI chr 1:176,847,642...177,091,688
Ensembl chr 1:176,847,639...177,085,769
|
|
G |
Alb |
albumin |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of ALB protein |
CTD |
PMID:29128616 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ALPL protein |
CTD |
PMID:35739755 |
|
NCBI chr 4:137,469,042...137,523,695
Ensembl chr 4:137,469,044...137,523,695
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of APAF1 mRNA |
CTD |
PMID:37364641 |
|
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
|
|
G |
App |
amyloid beta precursor protein |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of APP mRNA |
CTD |
PMID:37810885 |
|
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
|
|
G |
Ar |
androgen receptor |
affects binding multiple interactions |
ISO |
di-n-octyl phthalate binds to AR protein di-n-octyl phthalate inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein] |
CTD |
PMID:14565775 PMID:28571686 |
|
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
|
|
G |
Arhgef10l |
Rho guanine nucleotide exchange factor 10-like |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of ARHGEF10L mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 4:140,241,796...140,393,318
Ensembl chr 4:140,241,796...140,393,323
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ATF4 mRNA |
CTD |
PMID:37364641 |
|
NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of BAK1 mRNA |
CTD |
PMID:37364641 |
|
NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of BAX protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of BAX protein |
CTD |
PMID:35739755 PMID:37364641 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of BCL2 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of BCL2 protein |
CTD |
PMID:35739755 PMID:37364641 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l11 |
BCL2 like 11 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of BCL2L11 protein |
CTD |
PMID:29128616 |
|
NCBI chr 2:127,967,958...128,004,467
Ensembl chr 2:127,967,958...128,004,467
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CASP3 protein |
CTD |
PMID:35739755 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp6 |
caspase 6 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of CASP6 protein |
CTD |
PMID:29128616 |
|
NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752
|
|
G |
Casp7 |
caspase 7 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of CASP7 protein |
CTD |
PMID:29128616 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp8 |
caspase 8 |
decreases expression multiple interactions |
EXP |
di-n-octyl phthalate results in decreased expression of CASP8 protein [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CASP8 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of CASP8 protein |
CTD |
PMID:29128616 PMID:35739755 PMID:37364641 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CASP9 protein |
CTD |
PMID:35739755 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of CAT mRNA |
CTD |
PMID:37364641 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccnd2 |
cyclin D2 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of CCND2 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156
|
|
G |
Ccni |
cyclin I |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of CCNI mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 5:93,329,796...93,354,348
Ensembl chr 5:93,329,792...93,354,354
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of CDH1 protein |
CTD |
PMID:37364641 |
|
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
|
|
G |
Cops5 |
COP9 signalosome subunit 5 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of COPS5 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 1:10,094,825...10,108,384
Ensembl chr 1:10,094,826...10,108,393
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CPT1A mRNA |
CTD |
PMID:35739755 |
|
NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CPT1B mRNA |
CTD |
PMID:35739755 |
|
NCBI chr15:89,300,608...89,310,065
Ensembl chr15:89,300,608...89,310,066
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CPT2 mRNA |
CTD |
PMID:35739755 |
|
NCBI chr 4:107,761,179...107,780,786
Ensembl chr 4:107,761,178...107,780,807
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CXCL1 mRNA |
CTD |
PMID:35739755 |
|
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
|
|
G |
Cyba |
cytochrome b-245, alpha polypeptide |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CYBA mRNA |
CTD |
PMID:35739755 |
|
NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
|
|
G |
Cybb |
cytochrome b-245, beta polypeptide |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CYBB mRNA |
CTD |
PMID:35739755 |
|
NCBI chr X:9,301,493...9,354,005
Ensembl chr X:9,301,491...9,354,010
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CYCS protein |
CTD |
PMID:35739755 |
|
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
|
|
G |
Cyp4a10 |
cytochrome P450, family 4, subfamily a, polypeptide 10 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of CYP4A10 mRNA |
CTD |
PMID:24496636 PMID:26519955 |
|
NCBI chr 4:115,375,484...115,390,846
Ensembl chr 4:115,375,461...115,390,846
|
|
G |
Cyp4a12b |
cytochrome P450, family 4, subfamily a, polypeptide 12B |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of CYP4A12B mRNA |
CTD |
PMID:26519955 |
|
NCBI chr 4:115,268,821...115,296,231
Ensembl chr 4:115,268,821...115,296,231
|
|
G |
Cyp4a14 |
cytochrome P450, family 4, subfamily a, polypeptide 14 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of CYP4A14 mRNA |
CTD |
PMID:26519955 |
|
NCBI chr 4:115,343,397...115,353,355
Ensembl chr 4:115,343,397...115,353,339
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of DDIT3 mRNA |
CTD |
PMID:37364641 |
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Dnajc8 |
DnaJ heat shock protein family (Hsp40) member C8 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of DNAJC8 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 4:132,262,859...132,281,053
Ensembl chr 4:132,262,861...132,281,053
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signalling 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ERN1 mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ERN1 protein |
CTD |
PMID:37364641 |
|
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
|
|
G |
Esr1 |
estrogen receptor 1 (alpha) |
affects binding multiple interactions |
ISO EXP |
di-n-octyl phthalate analog binds to ESR1 protein [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ESR1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ESR1 protein di-n-octyl phthalate inhibits the reaction [Estradiol results in increased activity of ESR1 protein] |
CTD |
PMID:15464722 PMID:28571686 PMID:35739755 PMID:37364641 |
|
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
|
|
G |
Esr2 |
estrogen receptor 2 (beta) |
affects binding multiple interactions |
ISO EXP |
di-n-octyl phthalate analog binds to ESR2 protein [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ESR2 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ESR2 protein di-n-octyl phthalate inhibits the reaction [Estradiol results in increased activity of ESR2 protein] |
CTD |
PMID:15464722 PMID:28571686 PMID:35739755 PMID:37364641 |
|
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
|
|
G |
Exoc6 |
exocyst complex component 6 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of EXOC6 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr19:37,525,181...37,672,499
Ensembl chr19:37,509,327...37,672,507
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of FASN mRNA |
CTD |
PMID:35739755 |
|
NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
|
|
G |
Fbp2 |
fructose bisphosphatase 2 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of FBP2 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr13:62,984,698...63,006,214
Ensembl chr13:62,984,691...63,006,236
|
|
G |
Gata4 |
GATA binding protein 4 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GATA4 mRNA |
CTD |
PMID:37364641 |
|
NCBI chr14:63,436,363...63,509,161
Ensembl chr14:63,436,371...63,509,141
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GCLC mRNA |
CTD |
PMID:37364641 |
|
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GGT1 protein |
CTD |
PMID:35739755 |
|
NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
|
|
G |
Gk |
glycerol kinase |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GK mRNA |
CTD |
PMID:35739755 |
|
NCBI chr X:84,745,543...84,820,425
Ensembl chr X:84,745,543...84,820,425
|
|
G |
Gls2 |
glutaminase 2 (liver, mitochondrial) |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GLS2 mRNA |
CTD |
PMID:37364641 |
|
NCBI chr10:128,030,504...128,045,873
Ensembl chr10:128,030,326...128,045,873
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GOT1 protein |
CTD |
PMID:35739755 |
|
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
|
|
G |
Gper1 |
G protein-coupled estrogen receptor 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GPER1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of GPER1 mRNA |
CTD |
PMID:35739755 PMID:37364641 |
|
NCBI chr 5:139,408,905...139,413,555
Ensembl chr 5:139,408,906...139,413,555
|
|
G |
Gpi1 |
glucose-6-phosphate isomerase 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GPI1 mRNA |
CTD |
PMID:37364641 |
|
NCBI chr 7:33,900,752...33,929,761
Ensembl chr 7:33,900,755...33,929,761
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
increases expression multiple interactions |
ISO EXP |
di-n-octyl phthalate results in increased expression of GPT protein [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GPT protein |
CTD |
PMID:34822940 PMID:35739755 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
multiple interactions |
ISO |
[Phthalic Acids results in increased abundance of di-n-octyl phthalate metabolite] which results in increased secretion of HAVCR1 protein |
CTD |
PMID:33052911 |
|
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
|
|
G |
Hbb-bs |
hemoglobin, beta adult s chain |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of HBB-BS mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 7:103,475,730...103,477,135
Ensembl chr 7:103,475,741...103,477,303
|
|
G |
Herpud2 |
HERPUD family member 2 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of HERPUD2 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 9:25,012,412...25,063,109
Ensembl chr 9:25,019,428...25,063,116
|
|
G |
Hk1 |
hexokinase 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of HK1 mRNA |
CTD |
PMID:37364641 |
|
NCBI chr10:62,104,634...62,215,699
Ensembl chr10:62,104,634...62,215,687
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of HMGCR mRNA |
CTD |
PMID:35739755 |
|
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
|
|
G |
Hmox1 |
heme oxygenase 1 |
decreases expression multiple interactions |
ISO EXP |
di-n-octyl phthalate results in decreased expression of HMOX1 protein [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of HMOX1 mRNA |
CTD |
PMID:34822940 PMID:37364641 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of HSD17B10 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr X:150,784,892...150,787,438
Ensembl chr X:150,784,841...150,787,438
|
|
G |
Hsp90b1 |
heat shock protein 90, beta (Grp94), member 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSP90B1 mRNA |
CTD |
PMID:37364641 |
|
NCBI chr10:86,526,705...86,541,308
Ensembl chr10:86,526,073...86,541,373
|
|
G |
Hspa1b |
heat shock protein 1B |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of HSPA1B mRNA |
CTD |
PMID:37810885 |
|
NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
|
|
G |
Hspa5 |
heat shock protein 5 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 protein |
CTD |
PMID:37364641 |
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Idh3g |
isocitrate dehydrogenase 3 (NAD+), gamma |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of IDH3G mRNA |
CTD |
PMID:37810885 |
|
NCBI chr X:72,822,569...72,830,471
Ensembl chr X:72,822,569...72,830,503
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of IFITM3 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 7:140,589,503...140,590,657
Ensembl chr 7:140,589,499...140,590,683
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of IL10 mRNA |
CTD |
PMID:35739755 |
|
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of IL13 mRNA |
CTD |
PMID:35739755 |
|
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of IL4 mRNA |
CTD |
PMID:35739755 |
|
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of IL6 mRNA |
CTD |
PMID:35739755 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Ing5 |
inhibitor of growth family, member 5 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of ING5 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 1:93,731,648...93,749,823
Ensembl chr 1:93,731,687...93,749,823
|
|
G |
Lcn2 |
lipocalin 2 |
multiple interactions |
ISO |
[Phthalic Acids results in increased abundance of di-n-octyl phthalate metabolite] which results in increased secretion of LCN2 protein |
CTD |
PMID:33052911 |
|
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
|
|
G |
Ldlr |
low density lipoprotein receptor |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of LDLR mRNA |
CTD |
PMID:35739755 |
|
NCBI chr 9:21,634,872...21,661,215
Ensembl chr 9:21,634,779...21,661,215
|
|
G |
Lhb |
luteinizing hormone beta |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased secretion of LHB protein |
CTD |
PMID:37364641 |
|
NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321
|
|
G |
Lss |
lanosterol synthase |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of LSS mRNA |
CTD |
PMID:35739755 |
|
NCBI chr10:76,367,303...76,392,973
Ensembl chr10:76,367,422...76,392,972
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of MAPK1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:35739755 PMID:37364641 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of MAPK14 protein |
CTD |
PMID:37364641 |
|
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of MAPK3 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:35739755 PMID:37364641 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation |
ISO |
di-n-octyl phthalate results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:34822940 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mid1 |
midline 1 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of MID1 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr X:168,468,178...168,773,692
Ensembl chr X:168,468,195...168,773,794
|
|
G |
mt-Atp6 |
ATP synthase 6, mitochondrial |
decreases expression |
ISO |
di-n-octyl phthalate results in decreased expression of ATP6 mRNA |
CTD |
PMID:34822940 |
|
NCBI chr MT:7,927...8,607
Ensembl chr MT:7,927...8,607
|
|
G |
mt-Atp8 |
ATP synthase 8, mitochondrial |
decreases expression |
ISO |
di-n-octyl phthalate results in decreased expression of ATP8 mRNA |
CTD |
PMID:34822940 |
|
NCBI chr MT:7,766...7,969
Ensembl chr MT:7,766...7,969
|
|
G |
mt-Co1 |
cytochrome c oxidase I, mitochondrial |
affects expression |
ISO |
di-n-octyl phthalate affects the expression of COX1 mRNA |
CTD |
PMID:34822940 |
|
NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872
|
|
G |
mt-Co2 |
cytochrome c oxidase II, mitochondrial |
affects expression |
ISO |
di-n-octyl phthalate affects the expression of COX2 mRNA |
CTD |
PMID:34822940 |
|
NCBI chr MT:7,013...7,696
Ensembl chr MT:7,013...7,696
|
|
G |
mt-Co3 |
cytochrome c oxidase III, mitochondrial |
decreases expression |
ISO |
di-n-octyl phthalate results in decreased expression of COX3 mRNA |
CTD |
PMID:34822940 |
|
NCBI chr MT:8,607...9,390
Ensembl chr MT:8,607...9,390
|
|
G |
Mtpn |
myotrophin |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of MTPN mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 6:35,485,759...35,516,823
Ensembl chr 6:35,485,841...35,516,823
|
|
G |
Mvd |
mevalonate (diphospho) decarboxylase |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of MVD mRNA |
CTD |
PMID:35739755 |
|
NCBI chr 8:123,160,335...123,170,161
Ensembl chr 8:123,160,340...123,170,161
|
|
G |
Mzt1 |
mitotic spindle organizing protein 1 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of MZT1 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr14:99,271,980...99,283,898
Ensembl chr14:99,271,980...99,283,570
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of NCF1 mRNA |
CTD |
PMID:35739755 |
|
NCBI chr 5:134,248,907...134,258,479
Ensembl chr 5:134,248,907...134,258,479
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
decreases expression multiple interactions |
ISO EXP |
di-n-octyl phthalate results in decreased expression of NFE2L2 protein [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of NFE2L2 mRNA |
CTD |
PMID:34822940 PMID:37364641 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Npm1 |
nucleophosmin 1 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of NPM1 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr11:33,102,498...33,114,143
Ensembl chr11:33,102,287...33,113,206
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
decreases expression |
ISO |
di-n-octyl phthalate results in decreased expression of NRF1 mRNA; di-n-octyl phthalate results in decreased expression of NRF1 protein |
CTD |
PMID:34822940 |
|
NCBI chr 6:30,047,984...30,153,462
Ensembl chr 6:30,047,987...30,153,457
|
|
G |
Nrip1 |
nuclear receptor interacting protein 1 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of NRIP1 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr16:76,084,291...76,170,930
Ensembl chr16:76,084,288...76,170,715
|
|
G |
Nucb2 |
nucleobindin 2 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of NUCB2 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 7:116,103,579...116,139,823
Ensembl chr 7:116,103,604...116,139,819
|
|
G |
Ocln |
occludin |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of OCLN protein |
CTD |
PMID:37364641 |
|
NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1, cytosolic |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of PCK1 mRNA |
CTD |
PMID:35739755 |
|
NCBI chr 2:172,994,866...173,001,067
Ensembl chr 2:172,994,841...173,001,066
|
|
G |
Pdk3 |
pyruvate dehydrogenase kinase, isoenzyme 3 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of PDK3 mRNA |
CTD |
PMID:37364641 |
|
NCBI chr X:92,798,923...92,875,756
Ensembl chr X:92,808,213...92,875,807
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of PDK4 mRNA |
CTD |
PMID:37364641 |
|
NCBI chr 6:5,483,351...5,496,278
Ensembl chr 6:5,483,351...5,496,309
|
|
G |
Pfkp |
phosphofructokinase, platelet |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of PFKP mRNA |
CTD |
PMID:37364641 |
|
NCBI chr13:6,629,910...6,699,096
Ensembl chr13:6,629,804...6,698,813
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of PGAM1 mRNA |
CTD |
PMID:37364641 |
|
NCBI chr19:41,900,310...41,907,104
Ensembl chr19:41,900,362...41,907,099
|
|
G |
Phlda1 |
pleckstrin homology like domain, family A, member 1 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of PHLDA1 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr10:111,342,147...111,344,510
Ensembl chr10:111,342,147...111,344,506
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of PIK3R1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of PIK3R1 protein |
CTD |
PMID:35739755 PMID:37364641 |
|
NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725
|
|
G |
Pink1 |
PTEN induced putative kinase 1 |
increases expression |
ISO |
di-n-octyl phthalate results in increased expression of PINK1 mRNA; di-n-octyl phthalate results in increased expression of PINK1 protein |
CTD |
PMID:34822940 |
|
NCBI chr 4:138,040,718...138,053,631
Ensembl chr 4:138,040,720...138,053,618
|
|
G |
Plekha3 |
pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 3 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of PLEKHA3 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 2:76,505,436...76,527,679
Ensembl chr 2:76,505,625...76,527,172
|
|
G |
Pole2 |
polymerase (DNA directed), epsilon 2 (p59 subunit) |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of POLE2 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr12:69,248,547...69,274,979
Ensembl chr12:69,248,547...69,274,969
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
increases activity |
EXP |
di-n-octyl phthalate results in increased activity of PPARA protein |
CTD |
PMID:24496636 |
|
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
|
|
G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
decreases expression |
ISO |
di-n-octyl phthalate results in decreased expression of PPARGC1A mRNA; di-n-octyl phthalate results in decreased expression of PPARGC1A protein |
CTD |
PMID:34822940 |
|
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
|
|
G |
Ppp1r7 |
protein phosphatase 1, regulatory subunit 7 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of PPP1R7 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 1:93,271,350...93,295,344
Ensembl chr 1:93,270,576...93,301,211
|
|
G |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of PTK2 protein |
CTD |
PMID:37364641 |
|
NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129
|
|
G |
Ptp4a1 |
protein tyrosine phosphatase 4a1 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of PTP4A1 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 1:30,979,384...30,988,838
Ensembl chr 1:30,979,383...30,988,390 Ensembl chr 1:30,979,383...30,988,390
|
|
G |
Rab5a |
RAB5A, member RAS oncogene family |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of RAB5A mRNA |
CTD |
PMID:37810885 |
|
NCBI chr17:53,786,262...53,814,706
Ensembl chr17:53,786,262...53,814,708
|
|
G |
Rars1 |
arginyl-tRNA synthetase 1 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of RARS mRNA |
CTD |
PMID:37810885 |
|
NCBI chr11:35,699,207...35,725,355
Ensembl chr11:35,699,208...35,725,333
|
|
G |
Rnf128 |
ring finger protein 128 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of RNF128 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr X:138,464,089...138,573,894
Ensembl chr X:138,464,065...138,573,894
|
|
G |
Rpl19-ps11 |
ribosomal protein L19, pseudogene 11 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of RPL19-PS11 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 8:19,542,922...19,543,625
Ensembl chr 8:19,542,952...19,543,542
|
|
G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of SCD1 mRNA |
CTD |
PMID:35739755 |
|
NCBI chr19:44,382,889...44,396,148
Ensembl chr19:44,382,894...44,396,318
|
|
G |
Shbg |
sex hormone binding globulin |
affects binding |
ISO |
di-n-octyl phthalate binds to SHBG protein |
CTD |
PMID:25349334 |
|
NCBI chr11:69,501,108...69,508,852
Ensembl chr11:69,505,630...69,508,731
|
|
G |
Shroom3 |
shroom family member 3 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of SHROOM3 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 5:92,831,294...93,113,618
Ensembl chr 5:92,831,294...93,113,177
|
|
G |
Sirt1 |
sirtuin 1 |
decreases expression |
ISO |
di-n-octyl phthalate results in decreased expression of SIRT1 mRNA; di-n-octyl phthalate results in decreased expression of SIRT1 protein |
CTD |
PMID:34822940 |
|
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
|
|
G |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC1A5 mRNA |
CTD |
PMID:37364641 |
|
NCBI chr 7:16,515,259...16,532,199
Ensembl chr 7:16,515,265...16,532,199
|
|
G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A1 mRNA |
CTD |
PMID:37364641 |
|
NCBI chr 4:118,966,001...118,994,527
Ensembl chr 4:118,965,908...118,995,180
|
|
G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of SLC2A2 mRNA |
CTD |
PMID:35739755 |
|
NCBI chr 3:28,752,052...28,782,510
Ensembl chr 3:28,752,052...28,785,508
|
|
G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A3 protein |
CTD |
PMID:37364641 |
|
NCBI chr 6:122,704,783...122,779,149
Ensembl chr 6:122,704,768...122,778,599
|
|
G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
increases expression |
ISO |
di-n-octyl phthalate results in increased expression of SLC5A5 mRNA |
CTD |
PMID:16257484 |
|
NCBI chr 8:71,335,529...71,345,429
Ensembl chr 8:71,335,533...71,345,401
|
|
G |
Sox4 |
SRY (sex determining region Y)-box 4 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of SOX4 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr13:29,132,902...29,137,682
Ensembl chr13:29,132,902...29,137,696
|
|
G |
Sqle |
squalene epoxidase |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of SQLE mRNA |
CTD |
PMID:35739755 |
|
NCBI chr15:59,186,941...59,203,042
Ensembl chr15:59,186,926...59,203,041
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
di-n-octyl phthalate results in increased expression of SQSTM1 mRNA; di-n-octyl phthalate results in increased expression of SQSTM1 protein |
CTD |
PMID:34822940 |
|
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
|
|
G |
Tfam |
transcription factor A, mitochondrial |
decreases expression |
ISO |
di-n-octyl phthalate results in decreased expression of TFAM mRNA; di-n-octyl phthalate results in decreased expression of TFAM protein |
CTD |
PMID:34822940 |
|
NCBI chr10:71,061,298...71,074,157
Ensembl chr10:71,061,294...71,074,110
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression multiple interactions |
EXP |
di-n-octyl phthalate results in increased expression of TGFB1 mRNA [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TGFB1 mRNA |
CTD |
PMID:29128616 PMID:35739755 |
|
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
|
|
G |
Tjp1 |
tight junction protein 1 |
decreases expression multiple interactions |
EXP |
di-n-octyl phthalate results in decreased expression of TJP1 mRNA [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of TJP1 protein |
CTD |
PMID:37364641 PMID:37810885 |
|
NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529
|
|
G |
Tmed7 |
transmembrane p24 trafficking protein 7 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of TMED7 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr18:46,718,995...46,730,602
Ensembl chr18:46,693,302...46,730,602
|
|
G |
Tmem80 |
transmembrane protein 80 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of TMEM80 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 7:140,908,046...140,917,069
Ensembl chr 7:140,907,652...140,917,069
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of TNF mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of TNF protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of TNF protein |
CTD |
PMID:35739755 PMID:37364641 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tomm20 |
translocase of outer mitochondrial membrane 20 |
decreases expression |
ISO |
di-n-octyl phthalate results in decreased expression of TOMM20 mRNA |
CTD |
PMID:34822940 |
|
NCBI chr 8:127,657,414...127,672,671
Ensembl chr 8:127,657,417...127,672,594
|
|
G |
Trp53 |
transformation related protein 53 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of and results in increased phosphorylation of TP53 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of TP53 mRNA |
CTD |
PMID:35739755 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Tspan1 |
tetraspanin 1 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of TSPAN1 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 4:116,019,078...116,024,818
Ensembl chr 4:116,019,066...116,024,798
|
|
G |
Ube2g2 |
ubiquitin-conjugating enzyme E2G 2 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of UBE2G2 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr10:77,458,155...77,481,824
Ensembl chr10:77,458,109...77,481,827
|
|
G |
Uqcrc2 |
ubiquinol cytochrome c reductase core protein 2 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of UQCRC2 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 7:120,234,412...120,258,746
Ensembl chr 7:120,234,399...120,258,747
|
|
G |
Vim |
vimentin |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of VIM protein |
CTD |
PMID:29128616 |
|
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
|
|
G |
Vps25 |
vacuolar protein sorting 25 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of VPS25 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr11:101,144,533...101,150,377
Ensembl chr11:101,144,533...101,150,375
|
|
G |
Wasf2 |
WASP family, member 2 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of WASF2 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 4:132,857,843...132,927,067
Ensembl chr 4:132,857,816...132,927,067
|
|
G |
Zc3h11a |
zinc finger CCCH type containing 11A |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of ZC3H11A mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 1:133,547,600...133,589,137
Ensembl chr 1:133,547,600...133,589,118
|
|
G |
Zfand1 |
zinc finger, AN1-type domain 1 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of ZFAND1 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 3:10,405,013...10,416,383
Ensembl chr 3:10,405,013...10,416,377
|
|
G |
Zfp330 |
zinc finger protein 330 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of ZFP330 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr 8:83,490,247...83,500,774
Ensembl chr 8:83,490,236...83,500,789
|
|
G |
Zfp960 |
zinc finger protein 960 |
increases expression |
EXP |
di-n-octyl phthalate results in increased expression of ZFP960 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr17:17,284,365...17,309,893
Ensembl chr17:17,284,375...17,309,890
|
|
G |
Zswim6 |
zinc finger SWIM-type containing 6 |
decreases expression |
EXP |
di-n-octyl phthalate results in decreased expression of ZSWIM6 mRNA |
CTD |
PMID:37810885 |
|
NCBI chr13:107,861,152...108,026,598
Ensembl chr13:107,861,152...108,026,598
|
|